Eight Weeks Left For Consortia To Apply For Over E165m Of Innovative Health Initiative Funding
The 20 September deadline for proposals takes the EU one step closer to the appointment of the first new Innovative Health Initiative IHI consortia involving medtech.
You may also be interested in...
Two Massachusetts-based infusion pump manufacturers with the same founder and CEO received warning letters from the US FDA for similar violations.
More rolling reviews, a reduction in review rounds, and a rise in applications through two international regulatory collaboration initiatives were among the factors behind a reduction in new drug authorization times in Switzerland last year. However, “submission gaps” versus other regulators remain a problem.
The Paris-headquartered company has thrown in the towel on its oral SERD, leaving Roche, Eli Lilly and AstraZeneca to pursue Menarini in the field.